These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28886699)

  • 1. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
    Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
    BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.
    Kawabori M; Kuroda S; Shichinohe H; Kahata K; Shiratori S; Ikeda S; Harada T; Hirata K; Tha KK; Aragaki M; Terasaka S; Ito YM; Nishimoto N; Ohnishi S; Yabe I; Kudo K; Houkin K; Fujimura M
    Med; 2024 May; 5(5):432-444.e4. PubMed ID: 38547868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials.
    Shichinohe H; Houkin K
    Neurol Med Chir (Tokyo); 2016 Oct; 56(10):592-596. PubMed ID: 27302193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
    Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
    Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-, middle- and long-term safety of superparamagnetic iron oxide-labeled allogeneic bone marrow stromal cell transplantation in rat model of lacunar infarction.
    Tan C; Shichinohe H; Abumiya T; Nakayama N; Kazumata K; Hokari M; Hamauchi S; Houkin K
    Neuropathology; 2015 Jun; 35(3):197-208. PubMed ID: 25376270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats.
    Chen C; Cheng Y; Chen J
    J Neurosci Res; 2011 Aug; 89(8):1194-202. PubMed ID: 21544853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
    Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
    Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
    Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
    Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
    Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
    Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.
    Nagpal A; Kremer KL; Hamilton-Bruce MA; Kaidonis X; Milton AG; Levi C; Shi S; Carey L; Hillier S; Rose M; Zacest A; Takhar P; Koblar SA
    Int J Stroke; 2016 Jul; 11(5):575-85. PubMed ID: 27030504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.
    Osanai T; Houkin K; Uchiyama S; Minematsu K; Taguchi A; Terasaka S
    Int J Stroke; 2018 Jun; 13(4):444-448. PubMed ID: 29134924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice.
    Chau MJ; Deveau TC; Gu X; Kim YS; Xu Y; Yu SP; Wei L
    BMC Neurosci; 2018 Apr; 19(1):20. PubMed ID: 29649974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium Ferulate combined with bone marrow stromal cell treatment ameliorating rat brain ischemic injury after stroke.
    Zhao Y; Guan Y; Xu Y; Li Y; Wu W
    Brain Res; 2012 Apr; 1450():157-65. PubMed ID: 22424793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice.
    Song M; Mohamad O; Gu X; Wei L; Yu SP
    Cell Transplant; 2013; 22(11):2001-15. PubMed ID: 23069268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of micron-sized superparamagnetic iron oxide particles as markers for detection of migration of bone marrow-derived mesenchymal stromal cells in a stroke model.
    Tarulli E; Chaudhuri JD; Gretka V; Hoyles A; Morshead CM; Stanisz GJ
    J Magn Reson Imaging; 2013 Jun; 37(6):1409-18. PubMed ID: 23712844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemia.
    Zhang Q; Zhao Y; Xu Y; Chen Z; Liu N; Ke C; Liu B; Wu W
    J Transl Med; 2016 Jul; 14(1):223. PubMed ID: 27465579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
    Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
    Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Mechanism of Therapeutic Effect of 3-Methyl-1-phenyl-2-pyrazolin-5-one and Bone Marrow Stromal Cells Combination Treatment in Rat Ischemic Stroke Model.
    Shen LH; Chen J; Shen HC; Ye M; Liu XF; Ding WS; Sheng YF; Ding XS
    Chin Med J (Engl); 2016 Jun; 129(12):1471-6. PubMed ID: 27270545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.